Literature DB >> 28097635

Treatment of Functional Impairment in Patients with Bipolar Disorder.

Jose Sanchez-Moreno1, Anabel Martinez-Aran1, Eduard Vieta2.   

Abstract

Traditionally, functional impairment has received little attention in bipolar disorder, despite the fact that many patients experience significant impairments in daily life. In the last decade, research has changed its focus from clinical remission to functional recovery in bipolar patients as a priority. A literature review of this topic will allow us provide an overview of the relevance of functional impairment as well as the potential factors that can predict or contribute to low functioning in bipolar disorder (BD). Treatment approaches should consider not only euthymia as a goal but also cognitive and functional improvement of patients with such a complex disorder. Functional remediation and psychoeducation among psychological interventions may help to enhance functioning. The combination of cognitive enhancers and cognitive/functional remediation programs may help in improving cognitive and functional impairments. Early interventions are essential to prevent cognitive deficits and disability.

Entities:  

Keywords:  Bipolar disorder; Functional impairment; Functional remediation; Neurocognitive impairment; Psychoeducation; Treatment

Mesh:

Substances:

Year:  2017        PMID: 28097635     DOI: 10.1007/s11920-017-0752-3

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  63 in total

1.  Cognition as a target in schizophrenia, bipolar disorder and depression.

Authors:  Anabel Martinez-Aran; Eduard Vieta
Journal:  Eur Neuropsychopharmacol       Date:  2015-01-19       Impact factor: 4.600

2.  Functional remediation for patients with bipolar II disorder: improvement of functioning and subsyndromal symptoms.

Authors:  Brisa Solé; C Mar Bonnin; María Mayoral; Benedikt L Amann; Imma Torres; Ana González-Pinto; Esther Jimenez; Jose Manuel Crespo; Francesc Colom; Rafael Tabarés-Seisdedos; Maria Reinares; Jose Luis Ayuso-Mateos; Sara Soria; M Paz Garcia-Portilla; Ángela Ibañez; Eduard Vieta; Anabel Martinez-Aran; Carla Torrent
Journal:  Eur Neuropsychopharmacol       Date:  2014-05-20       Impact factor: 4.600

3.  Functional impairment and disability across mood states in bipolar disorder.

Authors:  Adriane R Rosa; María Reinares; Erin E Michalak; C Mar Bonnin; Brisa Sole; Carolina Franco; Mercè Comes; Carla Torrent; Flávio Kapczinski; Eduard Vieta
Journal:  Value Health       Date:  2010-12       Impact factor: 5.725

4.  The psychometric validation of the Sheehan Disability Scale (SDS) in patients with bipolar disorder.

Authors:  Robert Arbuckle; Mark A Frye; Martin Brecher; Björn Paulsson; Kitty Rajagopalan; Susan Palmer; Alessio Degl' Innocenti
Journal:  Psychiatry Res       Date:  2008-11-29       Impact factor: 3.222

5.  Neural correlates of improved executive function following erythropoietin treatment in mood disorders.

Authors:  K W Miskowiak; M Vinberg; L Glerup; O B Paulson; G M Knudsen; H Ehrenreich; C J Harmer; L V Kessing; H R Siebner; J Macoveanu
Journal:  Psychol Med       Date:  2016-03-21       Impact factor: 7.723

6.  The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence.

Authors:  Mauricio Tohen; Carlos A Zarate; John Hennen; Hari-Mandir Kaur Khalsa; Stephen M Strakowski; Priscilla Gebre-Medhin; Paola Salvatore; Ross J Baldessarini
Journal:  Am J Psychiatry       Date:  2003-12       Impact factor: 18.112

7.  A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission.

Authors:  Francesco Colom; Eduard Vieta; Anabel Martinez-Aran; Maria Reinares; Jose Manuel Goikolea; Antonio Benabarre; Carla Torrent; Merce Comes; Barbara Corbella; Gemma Parramon; Josep Corominas
Journal:  Arch Gen Psychiatry       Date:  2003-04

8.  A pilot study of a combined group and individual functional remediation program for patients with bipolar I disorder.

Authors:  Susan Zyto; Nienke Jabben; Peter F J Schulte; Barbara J Regeer; Ralph W Kupka
Journal:  J Affect Disord       Date:  2016-01-13       Impact factor: 4.839

9.  A randomized controlled trial of cognitive remediation and d-cycloserine for individuals with bipolar disorder.

Authors:  Nicholas Jk Breitborde; Spencer C Dawson; Cindy Woolverton; David Dawley; Emily K Bell; Kaila Norman; Angelina Polsinelli; Beth Bernstein; Pamela Mirsky; Christine Pletkova; Felix Grucci; Carly Montoya; Bernard Nanadiego; Ehsan Sarabi; Michael DePalma; Francisco Moreno
Journal:  BMC Psychol       Date:  2014-10-10

10.  Effects on health-related quality of life in patients treated with lurasidone for bipolar depression: results from two placebo controlled bipolar depression trials.

Authors:  Krithika Rajagopalan; Elizabeth Dansie Bacci; Daisy Ng-Mak; Kathy Wyrwich; Andrei Pikalov; Antony Loebel
Journal:  BMC Psychiatry       Date:  2016-05-23       Impact factor: 3.630

View more
  13 in total

Review 1.  [Psychotherapy for people with bipolar disorders : An overview of evidence-based procedures and new developments].

Authors:  T J Stamm; L-M Sondergeld; G Juckel; M Bauer
Journal:  Nervenarzt       Date:  2018-03       Impact factor: 1.214

2.  Sustained Attention and Working Memory Predict the Number of Days on Health-Related Benefits in the Year Following Occupational Rehabilitation.

Authors:  Thomas Johansen; Irene Øyeflaten; Hege R Eriksen; Peter S Lyby; Winand H Dittrich; Inge Holsen; Hanne Jakobsen; Ruby Del Risco Kollerud; Chris Jensen
Journal:  J Occup Rehabil       Date:  2021-01-20

Review 3.  Cognitive Impairment in Bipolar Disorder: Treatment and Prevention Strategies.

Authors:  Brisa Solé; Esther Jiménez; Carla Torrent; Maria Reinares; Caterina Del Mar Bonnin; Imma Torres; Cristina Varo; Iria Grande; Elia Valls; Estela Salagre; Jose Sanchez-Moreno; Anabel Martinez-Aran; André F Carvalho; Eduard Vieta
Journal:  Int J Neuropsychopharmacol       Date:  2017-08-01       Impact factor: 5.176

4.  Executive functioning but not IQ or illness severity predicts occupational status in bipolar disorder.

Authors:  Julia Drakopoulos; Timea Sparding; Caitlin Clements; Erik Pålsson; Mikael Landén
Journal:  Int J Bipolar Disord       Date:  2020-02-07

5.  Family and Psychosocial Functioning in Bipolar Disorder: The Mediating Effects of Social Support, Resilience and Suicidal Ideation.

Authors:  Wenbo Dou; Xueying Yu; Hengying Fang; Dali Lu; Lirong Cai; Caihong Zhu; Kunlun Zong; Yingjun Zheng; Xiaoling Lin
Journal:  Front Psychol       Date:  2022-01-28

6.  The mood disorder spectrum vs. schizophrenia decision tree: EDIPHAS research into the childhood and adolescence of 205 patients.

Authors:  Mathilde Léger; Vanessa Wolff; Bernard Kabuth; Eliane Albuisson; Fabienne Ligier
Journal:  BMC Psychiatry       Date:  2022-03-18       Impact factor: 3.630

7.  A system biology approach based on metabolic biomarkers and protein-protein interactions for identifying pathways underlying schizophrenia and bipolar disorder.

Authors:  Md Altaf-Ul-Amin; Kazuhisa Hirose; João V Nani; Lucas C Porta; Ljubica Tasic; Shaikh Farhad Hossain; Ming Huang; Naoaki Ono; Mirian A F Hayashi; Shigehiko Kanaya
Journal:  Sci Rep       Date:  2021-07-14       Impact factor: 4.379

8.  Affective lability across psychosis spectrum disorders.

Authors:  Margrethe Collier Høegh; Ingrid Melle; Sofie R Aminoff; Jannicke Fjæra Laskemoen; Camilla Bakkalia Büchmann; Torill Ueland; Trine Vik Lagerberg
Journal:  Eur Psychiatry       Date:  2020-05-06       Impact factor: 5.361

9.  Adjuvant psychotherapy in early-stage bipolar disorder: study protocol for a randomized controlled trial.

Authors:  Thomas J Stamm; Julia C Zwick; Grace O'Malley; Lene-Marie Sondergeld; Martin Hautzinger
Journal:  Trials       Date:  2020-10-13       Impact factor: 2.279

10.  Functional Disability in Patients with Mood Disorders at St Paul's Hospital Psychiatry Clinic, Addis Ababa, Ethiopia, 2019.

Authors:  Elias Tesfaye; Chalachew Kassaw; Liyew Agenagnew
Journal:  Patient Relat Outcome Meas       Date:  2021-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.